BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Triantafillidis JK, Zografos CG, Konstadoulakis MM, Papalois AE. Combination treatment of inflammatory bowel disease: Present status and future perspectives. World J Gastroenterol 2024; 30(15): 2068-2080 [PMID: 38681984 DOI: 10.3748/wjg.v30.i15.2068]
URL: https://www.wjgnet.com/1007-9327/full/v30/i15/2068.htm
Number Citing Articles
1
Galina V. Lukina, Oleg V. Knyazev, Elena A. Belousova, Diana I. Abdulganieva, Elena N. Aleksandrova, Igor G. Bakulin, Olga I. Barysheva, Maria А. Borisova, Bella А. Vykova, Alla А. Godzenko, Irina V. Gubonina, Tatiana V. Dubinina, Tatiana N. Zhigalova, Evgeny V. Zhilyaev, Anna V. Kagramanova, Tatiana V. Korotaeva, Alexander V. Kuzin, Maria A. Livzan, Aleksander M. Lila, Vadim I. Mazurov, Evgeny L. Nasonov, Alexander A. Novikov, Marina F. Osipenko, Asfold I. Parfenov, Larisa V. Tarasova, Olga V. Khlynova, Marina V. Shapina, Oksana B. Shchukina, Shandor F. Erdes, Aleksei A. Iakovlev. Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseasesTerapevticheskii arkhiv 2025; 97(2): 198 doi: 10.26442/00403660.2025.02.203117
2
Pengfei Zhang, Bing Pei, Chengxue Yi, Francis Atim Akanyibah, Fei Mao. The role of suppressor of cytokine signaling 3 in inflammatory bowel disease and its associated colorectal cancerBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025; 1871(2): 167578 doi: 10.1016/j.bbadis.2024.167578
3
Mariam Narous, Zoann Nugent, Inna Rabinovich-Nikitin, Lorrie Kirshenbaum, Charles N Bernstein. Cardiac arrhythmia in patients with inflammatory bowel disease: a retrospective, population-based cohort study in Manitoba, CanadaBMJ Open 2025; 15(3): e097687 doi: 10.1136/bmjopen-2024-097687
4
Kristyna Gabova, Hana Bednarikova, Zdenek Meier, Peter Tavel. Exploring intimacy and family planning in Inflammatory Bowel Diseases: a qualitative studyAnnals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2401610
5
Jia-Wang Yan, Mei Nie, Hang Zhang, Yan-Miao Liu, Fu-Shan Tang. Strengths, weaknesses, opportunities, and threats analysis of combination therapy for inflammatory bowel diseaseWorld Journal of Gastroenterology 2025; 31(9): 100607 doi: 10.3748/wjg.v31.i9.100607
6
Sophie Vieujean, Laurent Peyrin-Biroulet. Triple biologic therapy for refractory Crohn’s diseaseJournal of Crohn's and Colitis 2025; 19(5) doi: 10.1093/ecco-jcc/jjaf067
7
Ya-Xiong Guo, Xiong Yan, Xu-Chang Liu, Yu-Xiang Liu, Chun Liu. Artificial intelligence-driven strategies for managing renal and urinary complications in inflammatory bowel diseaseWorld Journal of Nephrology 2025; 14(1): 100825 doi: 10.5527/wjn.v14.i1.100825
8
Jeffrey A Lowell, Michael J Farber, Keith Sultan. Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel diseaseWorld Journal of Gastroenterology 2024; 30(25): 3182-3184 doi: 10.3748/wjg.v30.i25.3182
9
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
10
Qi-Hang Yang, Chuang-Nian Zhang. Comparative study on the pathogenesis of Crohn’s disease and ulcerative colitisWorld Journal of Gastroenterology 2025; 31(19): 106406 doi: 10.3748/wjg.v31.i19.106406
11
Antonio M Caballero-Mateos, Guillermo Arturo Cañadas-de la Fuente. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis managementWorld Journal of Gastroenterology 2024; 30(35): 3942-3953 doi: 10.3748/wjg.v30.i35.3942
12
Alexandra Olate-Briones, Sofía Albornoz-Muñoz, Francisca Rodríguez-Arriaza, Valentina Rodríguez-Vergara, Juan Machuca Aguirre, Chaohong Liu, Carlos Peña-Farfal, Noelia Escobedo, Andrés A. Herrada. Yerba Mate (Ilex paraguariensis) Reduces Colitis Severity by Promoting Anti-Inflammatory Macrophage PolarizationNutrients 2024; 16(11): 1616 doi: 10.3390/nu16111616
13
Wen-Ting Xie, Hui Yang, Lan Bai, Feng-Fei Wu. New perspectives and prospects for the next generation of combination therapy in inflammatory bowel diseaseWorld Journal of Gastroenterology 2025; 31(5): 99462 doi: 10.3748/wjg.v31.i5.99462
14
Lucia Centanni, Clelia Cicerone, Fabrizio Fanizzi, Ferdinando D’Amico, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Laurent Peyrin-Biroulet, Silvio Danese, Mariangela Allocca. Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine ApproachesPharmaceuticals 2025; 18(1): 78 doi: 10.3390/ph18010078
15
Stefan Schreiber, Jean-Frederic Colombel, Stephen B Hanauer, William J Sandborn, Silvio Danese, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Sun Hee Lee, Seul Gi Lee, Joon Ho Lee, Jong Min Kim, Ga Hee Park, Jimin Lee, Ju Hyun Lee, Chae Young Kim, Bruce E Sands. Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC StudiesInflammatory Bowel Diseases 2025;  doi: 10.1093/ibd/izaf038
16
Mouhaned Y. Al-darwesh, Karukh Ali Babakr, Ibrahim Nazem Qader, Mohammed A. Mohammed. Antimicrobial, anti-inflammatory, and anticancer potential of green synthesis TiO2 nanoparticles using Sophora flavescens root extractChemical Papers 2025; 79(2): 1207 doi: 10.1007/s11696-024-03853-0
17
Barbara Macura, Aneta Kiecka, Marian Szczepanik. Intestinal permeability disturbances: causes, diseases and therapyClinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01496-9
18
Valeria Dipasquale, Claudio Romano. New Therapeutic Challenges in Pediatric Gastroenterology: A Narrative ReviewHealthcare 2025; 13(8): 923 doi: 10.3390/healthcare13080923
19
Lakshmi Thangavelu, Syam Mohan, Hassan A. Alfaifi, Abdullah Farasani, Soumya V. Menon, Pooja Bansal, Chhavi Choudhary, M Ravi Kumar, Raghav Vashishth, Afrah M.A. Al- Rihaymee, Sarvesh Rustagi, Anil K. Malhotra, Muhammed Shabil, Mahalaqua N. Khatib, Quazi S. Zahiruddin, Siddig I. Abdelwahab, Ganesh Bushi, Saleh H.A. Almasabi, Hayam A. Alrasheed, Ali A. Rabaan. Safety and efficacy of stem cell therapy for Crohn’s disease: an umbrella review of systematic reviewsInternational Journal of Surgery 2024; 110(12): 7495 doi: 10.1097/JS9.0000000000002104
20
Kazuo Yashima, Hiroki Kurumi, Naoyuki Yamaguchi, Hajime Isomoto. Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologicsExpert Review of Gastroenterology & Hepatology 2025; 19(3): 291 doi: 10.1080/17474124.2025.2469832
21
Wenqian Wang, Wenfu Cao, Shenyun Zhang, Dapeng Chen, Lihong Liu. The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel DiseaseInternational Journal of Molecular Sciences 2025; 26(5): 1996 doi: 10.3390/ijms26051996